Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-26-000002·CVI Investments, Inc.
Schedule 13G ownership disclosure
PLUS THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 72941H509
Event date: 2026-01-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 12,368,423 · Class: 6.9%
- Heights Capital Management, Inc.
Shares: 12,368,423 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-26-000002
- Form type
- SCHEDULE 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Jan 22, 2026
- Reporting period
- Jan 14, 2026
- Description
- Schedule 13G beneficial ownership